IPCA Laboratories Ltd

IPCA Laboratories Ltd launches Diulcus to address Diabetic Foot Ulcer (DFU) in India

Sri. Sunil Ghai, President Marketing, IPCA, Sri. Supreet Deshpande, CEO, NovaLead Pharma Pvt Ltd, IPCA, Sri. Premchand Godha, Chairman,IPCA, Sri. Ajit Jain, Managing Director, IPCA, Dr. Anil Pareek, President Medical affairs, Clinical research and Regulatory affairs. Mumbai (Maharashtra) [India], August 16: As per the ICMR-INDIAB (2023) study, 10 crore people in India suffer from diabetes, […]

Continue Reading

NovaLead’s Patented Repurposed Drug receives approval from CDSCO for the treatment of Diabetic Foot Ulcer (DFU) for India market

New Delhi (India), July 25: NovaLead Pharma Private Limited (NovaLead), the pioneer of drug repurposing in India announced today that the drug regulator in India, CDSCO has approved their patented Repurposed Drug for treatment of Diabetic Foot Ulcer (DFU) which is a global unmet medical need. With over 15% -25% of diabetic patients suffering from […]

Continue Reading